Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nesrina Imami

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|July 6, 2018
Progesterone Modulation of Pregnancy-Related Immune ResponsesNishel M Shah, Nesrina Imami, Mark R Johnson
Journal of HIV Therapy|January 30, 2003
Improving HIV-specific immune responses in HIV-infected patientsGareth Ad Hardy, Nesrina Imami, Frances M Gotch
European Journal of Immunology|October 2, 2002
Molecular quantitation of thymic output in mice and the effect of IL-7Jeffrey Pido-Lopez, Nesrina Imami, Deborah Andrew, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirsAntonio Pires, Gareth Hardy, Brian Gazzard, et al.
Frontiers in Immunology|March 6, 2013
Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell ResponsesNesrina Imami, Samantha J Westrop, Nathali Grageda, et al.
AIDS (London, England)|March 2, 2002
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphomaTom Powles, Nesrina Imami, Mark Nelson, et al.
Frontiers in Endocrinology|April 16, 2019
Progesterone-Related Immune Modulation of Pregnancy and LaborNishel M Shah, Pei F Lai, Nesrina Imami, et al.
Scientific Reports|March 21, 2023
Use of laboratory-developed assays in global HIV-1 treatment-monitoring and researchJemima Malisa, Mark Manak, Clive Michelo, et al.
HIV Medicine|January 26, 2025
Point-of-care nucleic acid testing - a step forward in controlling the HIV epidemic: A reviewSuleyman Sarp Pinar, Mark Manak, Shanmugam Saravanan, et al.
Journal of Virology|August 21, 2002
A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infectionNesrina Imami, Antonio Pires, Gareth Hardy, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|July 6, 2018
Progesterone Modulation of Pregnancy-Related Immune ResponsesNishel M Shah, Nesrina Imami, Mark R Johnson
Journal of HIV Therapy|January 30, 2003
Improving HIV-specific immune responses in HIV-infected patientsGareth Ad Hardy, Nesrina Imami, Frances M Gotch
European Journal of Immunology|October 2, 2002
Molecular quantitation of thymic output in mice and the effect of IL-7Jeffrey Pido-Lopez, Nesrina Imami, Deborah Andrew, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirsAntonio Pires, Gareth Hardy, Brian Gazzard, et al.
Frontiers in Immunology|March 6, 2013
Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell ResponsesNesrina Imami, Samantha J Westrop, Nathali Grageda, et al.
AIDS (London, England)|March 2, 2002
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphomaTom Powles, Nesrina Imami, Mark Nelson, et al.
Frontiers in Endocrinology|April 16, 2019
Progesterone-Related Immune Modulation of Pregnancy and LaborNishel M Shah, Pei F Lai, Nesrina Imami, et al.
Scientific Reports|March 21, 2023
Use of laboratory-developed assays in global HIV-1 treatment-monitoring and researchJemima Malisa, Mark Manak, Clive Michelo, et al.
HIV Medicine|January 26, 2025
Point-of-care nucleic acid testing - a step forward in controlling the HIV epidemic: A reviewSuleyman Sarp Pinar, Mark Manak, Shanmugam Saravanan, et al.
Journal of Virology|August 21, 2002
A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infectionNesrina Imami, Antonio Pires, Gareth Hardy, et al.
Pageof 6